A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo- planar imaging

Archives of Neurology

Volumn 57, Issue 7, 2000, Pages 1017-1021

  Filippi, Massimo ^a,b   Iannucci, Giuseppe ^a   Cercignani, Mara ^a   Rocca, Maria Assunta ^a   Pratesi, Arianna ^a   Comi, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN INJURY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; WHITE MATTER;

EID: 0033921195     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.7.1017     Document Type: Article

References (37)

1. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol. 1996;39:6-16.
2. Filippi M, Horsfield MA, Ader HI, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol. 1998;43:449-506.
3. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicate heterogeneity in pathogenesis. Brain Pathol. 1996;6:259-274.
4. Bruck W, Bitsh A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 1997;42:783-793.
5. Filippi M. The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998;64 (suppl):S52-S58.
6. Le Bihan D, Turner R, Pekar J, Moonen CTW. Diffusion and perfusion imaging by gradient sensitization: design, strategy and significance. J Magn Reson Imaging. 1991;1:7-8.
7. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1998;161:401-407.
8. Woessner DE. NMR spin-echo self-diffusion measurements on fluids undergoing restricted diffusion. J Phys Chem. 1963;67:1365-1367.
9. Larsson HB, Thomsen C, Frederiksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging. 1992;10:7-12.
10. Christiansen P, Gideon P, Thomsen C, et al. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acts Neurol Scand. 1993;87:195-199.
11. Horsfield MA, Lai M, Webb SL, et al. Apparent diffusion coefficient in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med. 1996;36:393-400.
12. Droogan AG, Clark CA, Werring DJ, Barker GJ, Miller DH. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging. 1999;17:653-661.
13. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology. 1999;52:1626-1632.
14. Cercignani M, Horsfield MA. An optimised pulse sequence for isotropically-weighted diffusion imaging. J Magn Reson. 1999;140:58-68.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
16. Lublin FD, Reingold SC. the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46:907-911.
17. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
18. Barkhof F, Filippi M, vanWaesberghe JH, et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology. 1997;49:1682-1688.
19. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol. 1997;244: 266-270.
20. Studholme C, Hill DLG, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys. 1996;24:25-35.
21. Warach S, Chien D, Li W, Ronthal M, Edelamn RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology. 1992;42:1717-1723.
22. de Crespigny A, Marks MP, Enzmann DR, Moseley ME. Navigated diffusion imaging of normal and ischemic human brain. Magn Reson Med. 1995;33:720-728.
23. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16:53-59.
24. Adams CMW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull. 1977;33:15-20.
25. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci. 1979; 41:81-91.
26. Trapp BD, Peterson J, Ransohof RM, Rudik R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;388:278-285.
27. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain. 1995;118:1583-1592.
28. Fu L, Mathews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 1998;121:101-103.
29. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology. 1995;45:478-482.
30. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization transfer measurements. Radiology. 1995; 96:511-515.
31. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 1999;52:588-594.
32. Keiper MD, Grossman RI, Hirsch JA, et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. AJNR Am J Neuroradiol. 1998;19:1489-1493.
33. Filippi M, Horsfield MA, Campi A, Mammi S, Pereira C. Comi G. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol. 1995;38:749-754.
34. Van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998;50:1282-1288.
35. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996;47:1469-1476.
36. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol. 1993;34:661-669.
37. Lassmann H. Pathology of multiple sclerosis. In: Compston A, Lassmann H, McDonald I, Matthews B, Wekerle H, eds, McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingstone; 1998;323-358.